Digital Health Today 360 with Dan Kendall

Women and girls in low/middle-income countries are facing an urgent unmet need for modern contraception. This World Contraception Day, join guest host Sophie Park, Managing Director at G4A Digital Health Bayer in conversation with Dr. Ariane de Hoog, Lead Access to Medicine, Community Engagement at Bayer, and Titilola Olaolu-Hassan, Co-Founder & COO at Zuri Health, for this vital discussion on harnessing digital health solutions to empower women and enhance healthcare accessibility in Africa.Topics include:[00:02:14] Background to Bayer’s interest in empowering Women’s health.[00:05:05] Zuri Health: Affordable healthcare for underserved communities.[00:06:28] Impact goals behind Zuri becoming a G4A Portfolio company.[00:11:37] How the Zuri Health platform directly improves girls' and women's access to healthcare.[00:14:08] The future beyond family planning for Zuri Health in partnership with Bayer.[00:15:53] Bayer’s impact goal to provide 100 million women access to modern contraception by 2030.[00:20:23] Empowering women to make informed decisions irrespective of locationGuest & Host Links Connect with Dan Kendall on LinkedIn Connect with Sophie Park on LinkedIn Connect with Dr. Ariane de Hoog on LinkedIn Connect with Titilola Olaolu-Hassan on LinkedIn Bayer G4A Zuri Health - Your-Life website - complimentary access to an array of educational and training resources on adolescent health and contraceptive counselling Digital Health Today would not be possible without the support of leading organizations. Thank you to:> Presenting Partner: Amalgam Rx> Contributing Partners and Sponsors: LSI | Lindus Health | Bayer G4AConnect on Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook</

The Digital Medicine Society (DiMe) and Moffitt Cancer Center have announced they are co-hosting CancerX, a new public-private partnership effort to rapidly accelerate the pace of cancer innovation in the U.S.Alongside the Office of the National Coordinator for Health Information Technology (ONC) and the Office of the Assistant Secretary for Health (OASH), Moffitt Cancer Center and DiMe are urging the healthcare and digital health sectors to boost technology-driven initiatives to combat cancer. The two groups are working together to accelerate cancer research advancements, and they invite other organizations to do the same.The Biden administration's revived Cancer Moonshot includes the new CancerX public-private partnership. According to officials, the goal is to use industry collaboration and disruptive innovation to lessen the burden of cancer on everyone.The CancerX program will focus on using digital innovation to reduce disparities and financial toxicity in cancer care and research, working with government organizations, and will enlist industry parties to help with the mammoth undertaking.CancerX uniquely blends DiMe’s expertise in convening cross-disciplinary groups to develop clinical-quality resources on a tech timeline with Moffitt’s top research and care experts working side-by-side to revolutionize cancer treatment, extend access to the highest-quality care, and save more lives. The initiative is open to all those working in the field who are committed to working collaboratively and share a vision of unleashing the power of innovation to design and create a future that's free of the burden of cancer.Topics include: What is the Digital Medicine Society? Announcing CancerX, key initiatives and membership structure Improving the global ecosystem Guest & Host Links Connect with Dan Kendall | LinkedIn Connect with Jennifer Goldsack | LinkedIn and listen to her episode from May 2019 CancerX Digital Medicine Society Dime Academy DiMe Society Slack Digital Health Today would not b

In this coffee talk with AmalgamRX we dive into the challenges being faced by health systems as they work to assess, develop, and implement solutions at the time of a clinical decision. We'll explore the major pain points that keep projects from reaching their full potential, what it takes to overcome these challenges and what you can do when you're developing a digital therapeutic solution for your organization. There's also some tips that apply to payers and pharma as they play a key role in the successful development and implementation of digital therapies.Guest Links and Resources: Connect with Jenni Main on LinkedIn Connect with Dr. Suzanne Clough on LinkedIn Visit https://amalgamrx.com/ Host Links: Connect with Dan Kendall: Twitter | LinkedIn Connect with Eugene Borukhovich: Twitter | LinkedIn Connect on Digital Health Today:Browse Episodes | Twitter | Linkedin | Facebook | InstagramConnect on Health Podcast Network:Browse Shows | Linkedin | Twitter | Facebook | Instagram Learn more about your ad choices. Visit megaphone.fm/adchoices

I’m glad to be back on the mic and bringing you this special episode of Digital Health Today 360. Why is this episode special? Let me explain.One of the goals of the Digital Health Today channel is to create a space where people can learn about great innovation that can improve the health of both individuals and entire populations. Over the years, as I’ve been creating my own show, I’ve also had the opportunity to expand and serve the health community in other ways. Along with my colleagues at Mission Based Media, we’ve created other audio-first resources to share more information. For example, we created Health Podcast Network to showcase other high-quality, human-centered and evidence-based podcasts. Health Podcast Network now has about 100 different health podcasts and 13,000 episodes. We also worked through the pandemic to add new shows to Digital Health Today such as the DTx Podcast with Eugene Borukhovich, where he dives into the nascent digital therapeutics industry.And, most recently, we launched a library of podcasts called Health Unmuted where we create and share short-format, narrated, audio stories to help people understand more about specific health conditions. We launched the proof-of-concept miniseries last year called COPD Podcast. In June we launched the 5-part miniseries about Alzheimer’s Disease, and this month, in July, we’ll launch a 7-part miniseries about Parkinson’s disease.Why am I explaining all this? Because all this work at the intersection of health and podcasting has given me a chance to experiment with different formats, styles, content and audiences, and it’s also made me realize that I love creating this show.  It’s also made me more aware than ever that there is so much more that needs to be shared.  So, in this special episode, as I fire up the recording studio and prepare some great conversations with guests over the coming weeks and months, I thought I’d stand aside and invite another podcaster who is doing some great work in an area that needs much more attention.  Georgie Kovacs is the founder and host of Fempower Health - the go-to resource for all things women’s health serving women, their providers, and companies looking to build and improve on products for women. Georgie is really open about her first-hand experience with infertility and endometriosis. With that experience, she was motivated to start a podcast - in the middle of COVID, and as a single par

Technology is under the microscope, as are the behaviors of the people who develop and deploy it.As technology impacts virtually every aspect of society, it's use within the life sciences goes beyond traditional bioethical topics. This creates a host of questions for people and businesses working at the forefront of health innovation.In this episode, hear Nick Bott, Global Head, Bioethics and Technology Ethics at Takeda as we discuss: What is being done to ensure that the decisions around the use of technology for our health and wellbeing are carefully considered and applied?  Whose job is it to address the ethical questions in the development of AI and ML algorithms?  How can life science companies lead the way in setting standards for ethical development? What can we learn from Tony Stark - otherwise known as Iron Man in the Marvel Cinematic Universe? What is a 'consequence scanning workshop'? What is the role of regulation in setting standards and principles? Episode Links and Resources: Learn More About Ethics and Compliance at Takeda Notre Dame-IBM Technology Ethics Lab Markkula Center for Applied Ethics at Santa Clara University About the Age of Ultron - a lesson in 'irresponsible innovation'? Hear the Coffee Talk about the Health Outcomes Observatory (H2O) Guest Host LinksConnect with Nick Bott on LinkedIn Connect on Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramConnect on Health Podcast Network:Browse Shows

Guest host Sophie Park interviews health economist Jane Sarasohn-Kahn for this fast-paced discussion about women's health, social determinants of health and the 'she-cession' in the wake of the COVID-19 pandemic.We've seen the headlines during COVID-19: Rising caseloads. Millions of lives lost. Economic devastation. Schools closed.But these only tell part of the story.The impact of the pandemic on mental and physical health extends far beyond those that are directly infected with the disease.Delayed diagnosis, canceled or delayed treatment, loss of employment and the collision of home and professional responsibilities has had a tremendous and long-lasting impact.Join Jane Sarasohn-Kahn and guest host Sophie Park in this discussion about the affects of the pandemic.For more discussion about women's health, check out the video panel with Jane and Sonia Millsom, Chief Commercial Officer of Maven Clinic, on the September 9 Digital Health Forum.Episode Links and Resources: Connect with Jane Sarasohn-Kahn: Website | Twitter | LinkedIn | Attend Digital Health Forum: Website | LinkedIn | Twitter Tune into Episode 16 with Kate Ryder, founder of Maven Clinic Guest Host Links Twitter @sophiemariepark Linkedin: https://www.linkedin.com/in/sophiemariepark/ Connect on Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramConnect on Health Podcast Network:Browse Shows | <a href="https://www.linkedin.com/showca

Every day, tech companies and governments frame the conversation around the use of data. With the proliferation of smartphones and wearable devices, online shopping, and home voice assistants, we leave a digital footprint with almost everything we do.While our data can be crunched to drive better insights on listening habits, activity levels, and consumer preferences. There's also a far more important application for our data: to improve human lives and health outcomes. In this coffee talk, we explore how leaders in the pharmaceutical industry are working with people, policy makers and providers to create solutions that will usher in a new era of healthcare solutions and services.This Coffee Talk is created with support from Takeda.Guest Links and Resources: Connect with Meni Styliadou: LinkedIn Connect with Takeda: Website | Twitter | LinkedIn Connect with H2O: Website | Twitter | LinkedIn | YouTube European Patient Forum: Website Innovative Medicines Initiative: Website | Twitter | LinkedIn | YouTube Host LinksConnect with Dan: Twitter | LinkedIn Connect on Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramConnect on Health Pod

The pandemic has illustrated how Social Determinants of Health (SDOH) can impact the spread of disease, access to vaccines and the levels of trust in and utilization of basic health services.Beyond the focus on SDOH by politicians, advocacy, groups, and charitable organizations, there are private and public commercial organizations that make it a priority to find and fund solutions that address the social and cultural barriers that reduce or limit access to care.One of those organizations is Bayer.In this conversation with Dominick Kennerson, Global Head of Bayer G4A, we discuss how equity, access and sustainability help set the course for their investment strategy.This Coffee Talk is created in partnership with our Sponsor, Bayer G4A. This year Bayer G4A is looking for companies creating solutions to 5 key challenges including oncology, radiology, mental health, women's health and cardio metabolic and renal diseases.  The Bayer G4A program is open to companies from pre-seed stage to Series A, and even more advanced companies with traction in the market. Apply to be a part of Bayer G4A here, and tell them you heard about it on Digital Health Today.The deadline to apply is June 20, 2021.Guest Links and Resources: Connect with Dom Kennerson: Twitter | LinkedIn Connect with Bayer G4A: Website | Twitter | LinkedIn | YouTube World Health Organization - Website | Constitution Host LinksConnect with Dan: Twitter | Linkedin Connect on Digital Health Today:Browse Episodes | Twitter | Linkedin | Facebook | <a href="https://w

Dr. David E Albert is a physician, engineer, inventor and serial entrepreneur, and he's the founder and Chief Medical Officer of Alivecor. Dr. Albert has developed life-saving technologies and products for more than 30 years, and he's turned a number of those inventions into tech startups, even before it was a trendy thing to do.Each year, over 20,000 students enrolled in medical schools across the US.Over 600,000 businesses are started each year in the US, and nearly half fail within five years; two-thirds fail within 10 years.So why do people who are on a path to a successful career in medicine decide to become entrepreneurs?Dr. Albert says that "a lot of people go into medicine because it's not very risky. And so there's a real juxtaposition between those people who go into medicine because it's a secure professional lifestyle, and being an entrepreneur."Back in January, 2011, Dr. Albert posted a four minute YouTube video showing how to turn an apple iPhone 4 into a wireless clinical quality cardiac event recorder. It's called AliveCor, and it looked like magic. Ten years later, the AliveCor company continues to grow and expand.Tune into this special episode as we highlight the twists of fate and deliberate decisions that shaped Dr. Albert's career, and hear how his work and companies continue to make a lasting impact in the delivery of care.Guest Links and Resources: Connect with Dr. Dave Albert: Twitter | LinkedIn | Connect with AliveCor: Website | Twitter | LinkedIn | YouTube Dr. Albert's 2011 YouTube video showing the AliveCor ECG Host Links Twitter @healthtechdan Linkedin: https://www.linkedin.com/in/dankendall/ Connect on Digital Health Today:Browse Episodes | Twitter | Linkedin | Facebook | InstagramConnect

In this episode, we dive into a topic that is very close to my heart: improving the lives of people with diabetes.You've certainly heard Kodak mentioned as a good example of how companies should *not* manage product development. A company that was once a household name is now known for missing out on the move to digital cameras.For as long as businesses have existed, there have been companies that didn't move with the times - and we're not just talking about steam trains and pocket watches. There are thousands of case studies from the modern era that can teach important business lessons; lessons about things we should do, and lessons about things we shouldn't.As the number of people with diabetes continues to climb globally, we see businesses working hard to adapt to the new and changing expectations of providers, employers and patients. Increasingly in healthcare, the innovation isn't just about a new technology or innovation. It's about creating sustainable business models that engage stakeholders across the value chain.To understand more about the internal and external factors and decisions that drive innovation, I invited Adam Berman to the show. Adam is Director of Franchise Marketing at Roche Diabetes Care. He has over 15 years of experience in marketing and business leadership primarily in the diabetes category. Tune in as we explore diabetes as a use-case for taking bold steps to deliver better outcomes and experiences. We explore the capabilities of new digital solutions that Roche has developed, and the decisions that have enabled their development.Note: Although Roche is a sponsor of the Digital Health Today platform, this episode is not a sponsored episode. I asked to interview Adam purely based on my professional and personal interests in gaining a better understanding of how Roche is driving digital solutions for better care, and to discuss what companies can and should do to succeed.Hope you enjoy it. ~ DanGuest's Links and Resources: Connect with Adam Berman: LinkedIn Roche Diabetes Care Platform Roche Diabetes Health Connection  Sulli the Diabetes Guru - Alexa Skill for managing diabetes MySugr Host Links Twitter @healthtechdan Linkedin

"In this episode, I'm excited to introduce you to yet another outstanding health innovation leader who is hosting another new show on Digital Health Today. His degrees are in engineering and business, and he is a writer, entrepreneur, investor, and advisor. He is a truly multi-talented person and I'm pleased to also call him a friend. I'm honored to introduce the host of the new Asia Pacific Edition of Digital Health Today, Tony Estrella."~ Dan Kendall, Founder of Digital Health TodayClick here to read the transcriptLinks and Resources: Connect with Tony Estrella: Twitter | LinkedIn | Personal Website Connect with Taliossa Read Tony's Book: Comatose FutureProofing Healthcare Full Whitepaper, Summary and Video: A Vision for Asia Pacific in 2050 Connect on Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramConnect on Health Podcast Network:Browse Shows | LinkedIn | Twitter | Facebook | InstagramDigital Health Today is made possible by the support of our sponsors. Special thanks to: <a href="https://digitalhea

In this episode, I have the pleasure of introducing you to one of the health sectors leading innovators, and probably one of the best known and, dare I say it, most loved, leaders I’ve had the pleasure of knowing in my 20 plus years working in healthcare: Eugene Borukhovich.He’s a serial intra- and entrepreneur, executive, venture builder, speaker & board advisor with a focus in digital health. He’s also the Chairman and Founding Board Member at YourCoach.Health and founder of Initium Impact Ventures. Prior to YourCoach, Eugene served as Global Head of Digital Health at Bayer. He has also co-founded and sold a doctor rating startup and a consulting company. Eugene recently relocated to Barcelona where he enjoys running, writing, traveling and spending time with his family.Be sure to subscribe to Eugene's new show on Digital Health Today focused on Digital Therapeutics.Click here to read the transcriptLinks and Resources: Connect with Eugene Borukhovich: Twitter | LinkedIn Connect with YourCoach.health: Website | Twitter HealthXL: Website | Twitter | Join an Event Subscribe to Exits & Outcomes Brian Dolan: Twitter | LinkedIn Follow Digital Health Today:Browse Episodes | Twitter | LinkedIn | Facebook | InstagramFollow Health Podcast Network:Browse Shows | LinkedIn | </strong

In this episode I welcome two executives from Bayer G4A. Bayer G4A has been a longtime sponsor of Digital Health Today. I caught up with Dominick Kennerson, Global Head G4A, Digital Health Partnerships at Bayer Pharmaceuticals. I also spoke with Sophie Park. Sophie is a veteran guest on the Digital Health Today program, and the Chief Strategist for Bayer G4A Partnerships.Dominick shared how a chance meeting at a Washington, D.C. bar began his path to a career in Europe. We also spoke about the impact of COVID-19 on the Bayer organization, and how it has changed the expectations and opportunities for companies of all sizes working to make a dent in healthcare. He also traces the early use of the term 'digital health' back to his time at Revolution Health.Agents of Change - A Virtual Digital Health Forum:Earlier this year, Bayer G4A had a call for applications. They are looking for innovative companies that are ready to make a difference in specific key challenge areas. After months of hard work and vetting all the applicants, they’re about to announce the finalists for this year’s Bayer G4A Program. While we don’t know the companies they’ve selected at the time of this recording, they will be announced very soon at a global virtual event taking place at 11am Eastern (5PM CET) on Wednesday, November 18, 2020.So, if you’re listening to this episode on or before Nov 18, click here to register to attend. And - if you missed it, scroll down to find names and links to the companies that have been accepted. Now without further ado, let’s tune into the conversation with Dominick Kennerson and Sophie ParkView TranscriptMeet the 2020 G4A Partners in the G4A Program! Caria - Manage menopause with confidence. Decipher Biosciences - A commercial-stage precision oncology company committed to improving patient care Sweetch - A clinically validated, personalized, AI disease management optimization platform. Oncare - Connects you with your care team, so that they can digitally support you in your therapy  Elly - Daily motivation and support for people living with a chronic condition Digital Health Today is made possible by the support of our sponsors. Thank you to: <a

Imagine this: You’re the founder of a digital health startup. You’ve been carefully selected and invited to participate in a brand new accelerator in Barcelona. At the start of the year, you say goodbye to your friends and family, you find a place in Barcelona to call home, and you focus on growing your business with the mentorship and support of one of the world’s leading pharmaceutical companies. And then, COVID-19 happens. How does that impact your strategy? How will it affect your success? And will the fight you wage for survival have an impact the healthcare sector at large?In this Coffee Talk we speak with Carlos Gallardo, the CEO and Founder of CG Health Ventures and a board member at Almirall. He has invested personally in about a dozen companies - including Washington DC-based Babyscripts, whose co-founder Juan Pablo Segura was a guest on episode 67. Carlos is based in Barcelona, and he often takes an active role in helping his companies develop their product market fit. Background:At the end of 2019, Almirall selected and invited 4 companies to participate in their first cohort - aka "First Harvest" - at the Digital Garden in beautiful Barcelona. Like all things in 2020, the plans had to change to adapt to our new reality. In the face of this global crisis, the startups have embraced and benefited from opportunities that no one predicted in January. And Almirall itself has benefited from the Digital Garden as well.In October 2020, Almirall launched their call for their second cohort - or, as they like to call it - their "Second Harvest." Find out more by visiting the Almirall Digital Garden Website. Applications are open until October 31, 2020, so don’t delay.View transcriptLinks and Resources: Apply to Almirall Digital Garden - Deadline is Oct 31, 2020! Connect with Carlos Gallardo: LinkedIn | CG Health Ventures Digital Garden's First Harvest: Haut.ai Derma2Go Uvisio Intrepida Analytics Connect on Digital Health Today:<a href="https://digitalhea

If you’ve been tuned into nearly any news channel recently, you’ve probably seen the announcement by Akili about the clearance they announced on June 15 for their product EndeavorRX. It is the first prescription treatment delivered through a video game which is designed to treat Pediatric ADHD. This was quickly followed by an announcement on June 23, 2020 of their CE Mark certification.Like many of you I’ve been tracking the work and progress at Akili for a long time, and I was excited to hear about this important milestone, and when the Akili team contacted me to see if I wanted to have a closer look at and try Endeavor RX, I couldn’t resist.I’ve downloaded it to my iPad and gave it a try, and I’m impressed. I can’t speak to the clinical aspects of the product, but based on the standards and expectations that we have from consumer focused products, this was a great experience. It’s well-designed, was easy to get set up, and it uses a great combination of graphics and sounds to engage the player. I love the way they are positioning this with the simple and memorable tagline - “Play your medicine”. That sort of sums it up.To learn more about the importance of this milestone and go a little deeper behind the headlines, I grabbed a few minutes to connect with Eddie Martucci, the Co-Founder and CEO at Akili Interactive Labs.Eddie shares what the recent FDA clearance and CE Mark approval mean to the business. We also discuss the commercialization plans, the volume and value of data created by digital tools, and how Digital Medicine and Digital Therapeutics will continue to transform the relationship between companies and people.View transcriptLinks and Resources: Connect with Eddie Martucci, PhD: Twitter | LinkedIn Connect with Akili Interactive Labs: Website | Twitter | LinkedIn Read the Press Release for FDA Clearance Read the Press Release for CE Mark Certification Lancet

For this special Coffee Talk, I invited Sophie Park, Chief Strategist for Bayer G4A Partnerships to discuss the opportunities for innovative companies to grow and partner with a global pharma company.The Bayer G4A program has continued to grow and succeed since 2013, and it has evolved to adapt to changing market forces, new business priorities and the unprecedented acceleration of innovation that has taken place at the intersection of health and technology. One of the challenges when an organization has a long history of success like that is that people begin to automatically associate what they knew about the program in previous years, and then overlay that to make presumptions about what the program is like this year.  For example - a lot of people think that G4A is simply an accelerator for early stage startups. In actual fact, they also have a very powerful partnership program which is designed to attract companies that can participate in joint ventures, commercial partnerships or even majority investments.  In this episode, we dispel some of these myths and give more insights on the progress and success of the G4A program and family.Learn more about Bayer G4A PartnershipLinks and Resources:Learn more about Bayer G4A: Web | Twitter Connect on Digital Health Today:Browse Episodes | Twitter | Linkedin | Facebook | InstagramConnect on Health Podcast Network:Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible by the support of our sponsors. Thank you to University of Chicago - Master of Science in Biomedical Informatics

When you visit a website, do you use the navigation menu? Or do you head to the lower right corner of your screen? T hat corner is where a little bit of internet magic happens and it’s becoming more prevalent, and having a great impact, in healthcare. It’s where you can get the answers and information you need just by typing in a few simple words or a question.That little chatbot can be repeated millions and billions of times and provide more natural human interactions and benefits to both the users and the organization that deployed it.To learn more about this technology and how it’s being applied in healthcare, I invited Dr. John Reeves to come share some insights.  Dr. Reeves is a global expert in the application of conversational AI to healthcare. He has over 25 years of experience as an engineer, primary care physician, and entrepreneur. He’s the CEO and founder of ConversationHealth, which is transforming how life sciences companies engage their patients and healthcare professionals through virtual conversations. Their company has developed a Pharma-specific SaaS platform that powers these human-like experiences across text, voice, and digital human channels, and he’s here to discuss some top tips about what companies should be thinking about when it comes to developing a chatbot solution of their own.John and his team put together a download we’re going to discuss - and I just want to remind you that the download and links to everything we discuss can be found in the show notes of your podcast player and at our website at digitalhealthtoday.com/podcasts.You can also find everything at our second home on Health Podcast Network on healthpodcastnetwork.com - along with hundreds of great episodes from outstanding podcasts across healthcare. Be sure to check that out.Episode Download:Download the Chatbot CanvasLinks and Resources: Connect with Dr. John Reeves: LinkedIn Connect with Conversation Health: Website | Twitter | LinkedIn Connect on Digital Health Today:Browse Episodes | Twitter | Linkedin | Facebook<s

With the combination of the Covid crisis and the increased awareness of mental health in the month of May (which is #MentalHealthAwarenessMonth) I wanted to dig deeper into mental health and find out what we can do as individuals and organizations to resource ourselves and those around us. Guest: Dr. William Kassler, Deputy Health Officer and Lead Population Health Officer at IBM Watson Health.  Dr. Kassler has held a variety of roles at Centers for Medicare and Medicaid Services (CMS), New Hampshire Department of Health and Human Services, and the Centers for Disease Control and Prevention (CDC). Dr. Kassler has received numerous awards from the United States Public Health Service, including the Surgeon General’s Meritorious Service Award, and the Bi-State Primary Care Association President’s Award for “unyielding dedication to community-based access to care for the poor and disadvantaged.” We certainly appreciate his dedication to serving people from across our communities.He’s still a practicing internist and continues to hold office hours in his role at IBM.In this episode, we discuss the role of self-care in developing resilience to conquer fear.Links and Resources Mentioned: Connect with Dr. William Kassler: Twitter | LinkedIn Connect with IBM: Website | Twitter 2017 National Survey on Drug Use and Health (NSDUH) How technology and data can improve access to mental health resources Protecting mental health during a pandemic- By Dr. William Kassler IBM.biz/covidhealth - Confronting the Coronavirus - The Latest on IBM's Efforts Empower your remote workforce during COVID-19 GRIT Mobile Tool For Veterans - Getting Results in Transition Connect on Digital Health Today:Browse Episodes | Twitter | <a href="https://www.linkedi

In 2017, approximately 19.7 million people aged 12 or older had a substance use disorder (SUD) related to their use of alcohol or illicit drugs in the past year, and an estimated 20.7 million people aged 12 or older needed substance use treatment (1).Sky News reports that calls have doubled to a helpline designed to support children whose parents are battling alcoholism (2). When traveling is not an option, what support and services are available to people who are battling Substance Use Disorder? In addition to the treatment and support needed to support and sustain their recovery, they are also confined in their homes and potentially dealing in close proximity to relationship, financial or work related problems.Our guest has first hand knowledge of what it’s like to battle addiction, and, fortunately she’s turned her attention on how to improve the situation for people on their own journeys to long-term recovery.Joining me in the health podcast studio is Daniela Tudor, who is recovering from substance use disorder. Daniela is the CEO of WeConnect Health Management. Their mission is to reverse the high relapse rate of those in their first year of recovery and over come the challenges of transitioning into long-term recovery. Daniela started the company with her co-founder Murphy Jensen, the former tennis pro and winner of the 1993 French Open Doubles title. We discuss the traditional tools, instructions and systems available for people in recovery, and how technology facilitates better solutions, experiences and outcomes, Daniela also shares how she and Murphy teamed up to start the company - it involves a 'Bucket List' competition and a trip to Sir Richard Branson's Necker Island.  Join WEconnect Recovery Live Every third Friday at 7pm Pacific/10pm EasternLinks and Resources: Connect with Daniela Tudor: Twitter | LinkedIn | TEDxBellevueWomen Connect with WeConnect Health Recovery: Website | Twitter | LinkedIn (1) https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHFFR2017/NSDUHFFR2017.pdf (2) https://news.sky.com/story/coronavirus-calls-to-charity-double-as-children-strug

Organizations are adapting to the new ways of engaging with their employees, clients and suppliers, and platforms like Zoom are experiencing rapid growth as collaboration tools. But successfully growing a business requires more than simply having the right technology in place. Ultimately, it's always about the people.Questions abound such as - how do you build a company culture when people can't gather in coffee rooms, common areas or ping pong tables? Are teleconferencing solutions like Zoom really the best option for people to experience human connection and interaction? And if the predictions are correct and this pandemic really will introduce an entirely new way for businesses to operate over the long term, how do you recruit and grow teams and create ways of building personal relationships that go beyond a voice and a video screen?To give some insights on how to do those things I turned to Dr Justin Barad, the co-founder and CEO of Osso VR. Justin shares an update on the growth of his company, and, importantly, he explains how Osso VR has created a company culture and a sense of teamwork, even though people rarely share the same physical space.  Justin and I prepared a PDF of some of the tips we discuss on this program, as well as a few links to some resources you may find useful. Be sure to grab those in the link below.Grab the Episode Download: Tips, Links and MoreLinks and Resources: Connect with Justin Barad: Twitter | LinkedIn Connect with Osso VR: Website | Twitter | Linkedin Study: Randomized Trial of a Virtual Reality Tool to Teach Surgical Technique for Tibial Shaft Fracture Intramedullary Nailing Press: Time Best Inventions 2019 Video: Watch a VR Team Meeting at Osso VR Hardware: Oculus for Business Software: MeetinVR | VSpatial | <a href="h

For this special Coffee Talk I invited two leaders from one of our sponsors to share some of their insights and expertise on one of the most important areas of healthcare right now, Biomedical Informatics. Organizing, analyzing, and utilizing vast amounts of information for translational research to connect discovery with clinical care is one of the biggest challenges facing the current generation of data scientists, which is particularly being highlighted during the current COVID-19 pandemic.The University of Chicago Master of Science in Biomedical Informatics is an amazing program that goes deep in informatics methodology. It also teaches things like effective communication skills and how to manage complex Biomedical Informatics projects, as well as entrepreneurial and innovation skills across the various courses.With me in our virtual studio is Dr. Sam Volchenboum and Dr. Cheng-Kai Kao to tell us more about the ways they’re training and preparing the leaders we need for the healthcare of today and tomorrow. They explain more about the program itself, the kinds of professionals who enroll, and how they go about preparing students for the roles they will have in healthcare.Be sure to check out the full transcript on our website.Links and Resources: Learn more about University of Chicago Master of Science in Biomedical Informatics: Web | Twitter Cheng-Kai Kao, MD: LinkedIn Sam Volchenboum, MD, PhD, MS: LinkedIn Connect on Digital Health Today:Browse Episodes | Twitter | Linkedin | Facebook | InstagramConnect on Health Podcast Network:Browse Shows | Linkedin | Twitter | Facebook | Instagram Digital Health Today is made possible

At some stage, hopefully soon, the COVID-19 crisis is going to be behind us. Regardless of what was done right or what mistakes are made, eventually, we’ll need to focus on the work we need to do in our 'new normal'. In this episode we consider two key questions.1) Based on the information that's available today, what decisions can we make today to make a positive impact? 2) Based on where we know we need to go, what can we do now to drive better decisions and prepare for the next challenge or obstacle? With me in our virtual studio is Dr. Zayna Khayat. Zayna is the Future Strategist with SE Health. SE Health was formerly known as St. Elizabeth Healthcare, which is a health and social impact enterprise based outside Toronto. SE Health has a major focus on creating a better future for aging adults in their homes and in their communities. Zayna is faculty at singularity University's exponential medicine stream, adjunct faculty in the health sector strategy stream at Rotman School of Management at the University of Toronto and the author of a new book entitled, ‘The Future of Aging’.Join us as we discuss the barriers that are finally coming down to enable a better present and future, and the steps organizations can begin making now to be prepared for our new reality.Links and Resources: Connect with Dr. Zayna Khayat: Twitter | LinkedIn Connect with SE Health: Website | Twitter Amazon link to Dr. Khayat's book 'The Future of Aging' Hear more about Zayna's book on her episode on 'Sherpa's Guide to Innovation' John Krasinski's YouTube Show "Some Good News" Episode 3 Shot of Digital Health Therapy w/Eugene Borukhovich and Jim Joyce Videos:Shot of #DigitalHealth Therapy - Ep0Baseball Is Back: Some Good News with John Krasinski (Ep. 3)Connect on Digital Health Today:Browse Episodes | <a href="ht

Joining me in our virtual studio is David Van Sickle, co-founder and CEO of Propeller Health. Propeller is a leading digital health company dedicated to the management of chronic respiratory disease. David founded Propeller Health in 2010 but he initially started his work in 2006 while at the University of Wisconsin in Madison.  David was one of the very early pioneers who spotted the ability to apply technology to medications to capture data that gives insights into both personal and population health. He and the team at propeller health worked tirelessly over the years to develop the technology, business models, regulatory approvals and evidence to drive adoption of their product.  Now, 14 years on, and this early digital health company is seeing a groundswell of interest as their products are used by some of the people who are most vulnerable to COVID-19. I wanted to know how their strong foundation and company mission supported their growth and evolution, and how, with their successful track record, they are supporting their users and communities to help them stay well and healthy. I was also interested to see if they’ve observed any changes in behavior by their users in the wake of the coronavirus pandemic.Links and Resources: Connect with David Van Sickle: Twitter | LinkedIn Connect with Propeller Health: Website | Twitter Nature Article "Improved asthma outcomes observed in the vicinity of coal power plant retirement, retrofit and conversion to natural gas" Connect on Digital Health Today:Browse Episodes | Twitter | Linkedin | Facebook | InstagramConnect on Health Podcast Network:Browse Shows | Linkedin | Twitter | Facebook | <a href="https://www.instagram.com/healthp

There's a shortage of #PPE at the frontlines of care, and a nurse-led effort to address it.->> Click here to support #PPE for nurses at the front line > GoFundMe Page Our guest: Rebecca Love, RN, MSN, FIELRebecca is a thought leader on Nurse Innovation & Entrepreneurship. She designed and built the first nurse innovation program as the Director of Nurse Innovation & Entrepreneurship at Northeastern University in the US, was the first nurse featured on Ted.com, and is dedicated and passionate about empowering nurses to be at the forefront of healthcare innovation and entrepreneurship.She is also a Vice President of Optimize RX which provides a unique solution to patient adherence to medications. In a volunteer capacity, Rebecca is the Founder and President of SONSIEL, a charity she founded in which she works alongside an incredible board of nurse leaders to serve nurses across healthcare. Click here to Support the #GETTHEMPPE with #SONSIEL #GLOGOODLinks and Resources: Connect with Rebecca Love: LinkedIn Connect with SONSIEL: Website | Twitter Get Rebecca's Book: The Rebel Nurse Handbook: Inspirational Stories by Shift Disruptors Hashtags: #SONSIEL | #COVID19 | #getmeppe | #rallythenation | #masksConnect on Digital Health Today:Browse Episodes | Twitter | Linkedin | Facebook | InstagramConnect on Health Podcast Network:Browse Shows | <a href

Our guest: Shawna Butler, RN, MBAShawna is a nurse economist and tech enthusiast. She is a leading advocate for the role of nurses in driving the development and use of technology across the healthcare sector. She works with companies of all sizes, from startups to global corporations, and she’s coined the term ‘EntrepreNURSE’.Shawna works with the pioneers who are integrating robotics, 3D printing, drones, AI, mixed reality, voice recognition, digital humans, big data and sensors into our health solutions and lifestyles. Her clinical experience includes emergency, cardiac, and critical care in both large university and small community hospitals, as well as international medical flight transport, and workplace health promotion services. She’s lived and worked around the world, and if you’re heading to Austin for SXSW, you’ll be able to meet her there. Shawna gives us some tips on how to make the most of a visit to that event.One of the newest roles Shawna has on her resume is that of podcaster! That’s right, Shawna and her executive producer Rebecca McInroy have worked with the teams at American Nurses Association and Johnson and Johnson to create the See You Now Podcast. You can of course pick that up on all your favorite podcast catchers, as well as on the healthpodcastnetwork.com.Links and Resources: Connect with Shawna Butler: Twitter | LinkedIn Tune-in to See You Now Podcast: JnJ Website | ANA Website | Health Podcast Network Anna Sort - Twitter SXSW Exponential Medicine | Daniel Kraft, MD Connect on Digital Health Today:Browse Episodes | Twitter | Linkedin | Facebook | InstagramConne

Our guest: Dr. David Fajgenbaum is the co-founder & Executive Director of the Castleman Disease Collaborative Network and a Research Assistant Professor of Medicine at UPenn. After being diagnosed with Castleman disease as a 3rd year medical student and narrowly escaping death several times, David was told that there were no treatments available that could help him. David realized his only hope was to create a new model for advancing the fight again rare and deadly illnesses.With 25-30 million people with rare diseases in the US alone, there is a tremendous need for new approaches for repurposing and developing suitable treatments that can help them. David shares his experience in the lab and in life as he continues his fight to change the way we develop drugs and do research.Episode Download:Information About Fighting Rare DiseaseLinks and Resources: Connect with David Fajgenbaum: Web | LinkedIn | Twitter David's Blog about Innovation for Rare Diseases David's talk at Exponential Medicine Nov 2019 (video) David on Good Morning America (video) Link to David's book: Chasing My Cure Read more and donate to Castleman Disease Collaborative Network (CDCN.org) | Twitter | Instagram | Facebook RareDiseaseDay.org DOWNLOAD THE PDF FROM OUR WEBSITE  Digital Health Today is made possible by the support of our sponsors. Thank you! Learn more about your ad choices. Visit megaphone.fm/adchoices

Our guest: Dr. Jennifer Schneider, President of LivongoAfter speaking with Glen Tullman, Founder and Executive Chairman of Livongo, in an earlier episode, I was so interested in the work that Livongo is doing that I asked for a chance to speak with Dr. Jennifer Schneider when we were both in Las Vegas for the HLTH conference. Jenny is an amazing individual. She was diagnosed with Type 1 diabetes over 30 years ago and has a deep understanding the real-world impact of the condition. She's been a key part of leadership teams for two companies that have gone public in recent years. The most recent one, Livongo went public in July 2019 and was the most successful IPO of a digital health company in history. She’s also an athlete, the author of a book entitled Decoding Health Signals, and the proud parent to 3 wonderful children. She writes in her book that her goal at Livongo is to create a system of health and healthcare that they will inherit and be proud of - and no doubt benefit from.Tune in as Jennifer shares her own experience battling the complexities of T1D, and how health signals help improve outcomes for people facing chronic illness.Links and Resources: Jennifer Schneider on Twitter Jennifer Schneider LinkedIn   Jennifer's Book: Decoding Health Signals: Silicon Valley's Consumer-First Approach to a New Era of Health Glen Tullman's Book: On Our Terms: Empowering the New Health Consumer Podcast with Glen Tullman Livongo on Twitter Livongo on LinkedIn Livongo on the Web  Digital Health Today is made possible by the support of our sponsors. Thank you! Learn more about your ad choices. Visit megaphone.fm/adchoices

Our guest:In this episode, we speak with Robert Cohen, VP of Global R&D, Chief Technology Officer at Stryker Joint Replacement. Stryker is one of the world's leading medical technology companies, and is leading the development of new ways to transform and enhance the technology available in musculoskeletal care.  Robert shared some insights on the work Stryker is doing to improve surgical practice as well as capture more and better data about patient outcomes. We dive into the latest information about surgical robots, wearable sensors, and data, and explore the advances that may develop over the next 10 years.  Links and Resources: Robert Cohen on LinkedIn   Stryker on LinkedIn Stryker Orthopaedics on the Web Stryker Mako Technology Stryker Joint Replacement Smart Equipment Mgmt (Stryker) HoloLens in Germany (Virtual Surgery Intelligence) Microsoft Health  Website • Twitter  Link to Episode 96 with Molly McCarthy The Venue:This conversation was recorded at DOCSF in January 2020, the weekend before #JPM Week in San Francisco. DOCSF is all about the intersection of digital health and musculoskeletal care.This year, the sessions featured leaders from Microsoft, Google, Mozilla, Amazon and many other amazing organizations, and Dan Kendall interviewed some of the speakers following their sessions on the stage. This special series of episodes features some of the interviews recorded at this annual event. To hear all the sessions on the DOCSF podcast, be sure to subscribe to the DOCSF Podcast here or visit<a href="https://cms.megaphone.fm/organizations/6f5f92a2-7984-11e8-bcfc-b715c2319ea

Our guest: In this episode, we hear from Molly K. McCarthy MBA, BSN, RN-BC. Molly is the National Director, US Provider Industry and Chief Nursing Officer for Microsoft. Molly shares her path that led her from from nursing to technology leadership. Molly discusses the use of the HoloLens, education and the 3 key business areas at Microsoft Health, which are:1) Helping clients migrate to the cloud2) Helping to empower frontline clinicians3) Thinking about AI as it applies to further development of precision medicine.Links and Resources:Molly McCarthy onLinkedIn TwitterSmart Equipment Mgmt (Stryker)HoloLens in Germany (Virtual Surgery Intelligence)Microsoft Health  Website Twitter The Venue:This conversation was recorded at DOCSF in January 2020, the weekend before #JPM Week in San Francisco. Now in its fourth year, the Digital Orthopedics Conference, San Francisco, is organized by Prof Stefano Bini and Shawna Butler. This year, the sessions featured leaders from Microsoft, Google, Mozilla, Amazon and many other amazing organizations, and Dan Kendall interviewed some of the speakers following their sessions on the stage. This special series of episodes features some of the interviews recorded at this annual event. To hear all the sessions on the DOCSF podcast, be sure to subscribe to the DOCSF Podcast here or visit Health Podcast Network.Digital Health Today is made possible by the support of our sponsors. Thank you! Learn more about your ad choices. Visit megaphone.fm/adchoices

The DOCSF meeting is a great way to get geared up before #JPM Week in San Francisco. Now in its fourth year, the Digital Orthopedics Conference, San Francisco, is organized by Prof Stefano Bini and Shawna Butler. This year, the sessions featured leaders from Microsoft, Google, Mozilla, Amazon and many other amazing organizations, and I interviewed some of the speakers following their sessions on the stage. This special series of episodes features some of the interviews recorded at this annual event. To hear all the sessions on the DOCSF podcast, be sure to subscribe to the DOCSF Podcast here.Our guest:In this episode, I spoke to Dr. Daniel Kraft. Daniel is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has chaired the Medicine for Singularity University since its inception in 2008. He is also founder and chair of Exponential Medicine (next being held November 9-12, 2020), a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.Links and Resources:Daniel Kraft on LinkedIn  Personal Website  NEW! Digital.Health WebsiteExponential Medicine  Website Twitter Digital Health Today is made possible by the support of our sponsors. Thank you! Learn more about your ad choices. Visit megaphone.fm/adchoices

I recently had the opportunity to travel to Berlin Germany for the Bayer G4A Signing Day event. This was their official launch of the 11 inspiring companies that are the most recent additions to the G4A family. While I was there, I was fortunate to have the opportunity to speak with their keynote speaker for the evening. From the stage, he shared the story behind the success of his company, the impact it's having in real and powerful ways, and the focus on the company following their IPO in July of this year.That speaker was none other than Glen Tullman, the Executive Chairman and Founder of Livongo Health.Unless you’ve been living under a rock the past few years, you’ve heard about Livongo and the work they’re doing as a consumer-first, digital health company that’s committed to empowering people with chronic conditions to live better and healthier lives. Glen and I spoke about his mission to finding a cure for diabetes and other chronic conditions, and to keeping people healthy until these cures are found.Before Livongo, Glen previously ran two public companies that changed the way health care is delivered, and he is the author of a book entitled: On Our Terms: Empowering the New Health Consumer. In that book, he proposes new solutions to address the chronic-condition epidemic we’re facing.And while he’s achieved great success in business, he’s also a strong advocate of philanthropic causes. He was honored just this year with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy, and efficiency of our healthcare system.He also serves as a Chancellor to the International Board of the Juvenile Diabetes Research Foundation and as a Board Member of the American Diabetes Association.In addition to all this, Glen is a father to three amazing children that inspire him every day. I was inspired by our conversation, and I hope you’ll enjoy it as much as I did.Today's Topics: The importance of the recent announcement and what improvements and benefits can Livongo get from this new partnership What was the experience like building a new company from the ground up after having been a CEO of larger ventures What were the challenges faced along the way and why choose diabetes as the main focus for Livongo What was the experience like turning an applied health signals company into an IPO and, what does it mean to the brand and the challenges that came with it Glen's plan for Livongo for thier international consumers and creating more global partnerships Links and Resources Men

In this episode we dive into mental health. More specifically, the treatment of major depressive disorder, also known as clinical depression. It is an area of tremendous need and one can be very well served through the solutions and approaches that are being developed and being made available to users around the world.So, how big of a problem is severe depression? More than 300 million people of all ages suffer from depression, and at it’s worse, it can lead to suicide. Fewer than half of those suffering from depression are able to receive treatment due to limited resources, a lack of trained Health care providers, and of course, the social stigma that is still sadly associated with mental disorders.There’s a host of treatment options for depression but the effectiveness of the treatments depend on the type of depression and its severity and, of course, each individual’s adherence and response. Some of the options include Psychotherapy, Psychoeducation and Support Groups, Medications, and Brain Stimulation Therapies. None of these options provide instant relief, and, like in the case of medications, it’s sometimes not known for many weeks if the treatment is effective at all. Antidepressants, for example, often take two to four weeks to begin having an effect, and up to 12 weeks to reach full effect.With me today is Talia Cohen Solal, PhD, she’s the CEO and co-Founder of Genetika+. Genetika+ is developing a cellular and genetics-based platform to provide meaningful predictions of patient responses to antidepressants. Using biological, environmental and genetic data, they are developing a personalized solution for each patient to help them recover better and faster.Today's Topics: A quick background of Talia, her work and her on-going research focusing on mental health The current statistics, stages of depression and how it impacts and individual and the society as a whole The current treatment & medication available and how to measure their efficacy How the trial and error approach does a disservice to patients How the ‘Brain in a Dish' can accelerate patients getting onto therapies that produce the outcomes needed. Links and Resources Mentioned: Talia Solal on LinkedIn Genetika Plus on Twitter Genetika Plus on LinkedIn Genetika Plus on the Web Start-Up Nation Central and Start-Up Nation Finder National Institue of Mental Heal

“Don't fall in love with the solution, fall in love with the problem”…..Really?In this episode we look at needs-based innovation, and to get a better understanding I spoke with Marta Zanchi, PhD.Marta spent 13 years at Stanford University, first as a doctoral student then as a faculty member and founding director of digital health at the Stanford Byers Center for Biodesign. Her experience spans from designing software and hardware devices to walking the full process of health technology innovation.Marta has advised companies, spent time as a medical device fellow at the FDA, invested in companies through her role as an Equity Partner at Palo Alto-based DCVC, and she recently relocated to Barcelona where she’s the founder and managing partner of health-tech microVC fund Nina Capital. I’ve had the pleasure of knowing Marta for a few years, and when I took a fresh look at her LinkedIn profile, there was something written that I just think really puts Marta into context as a person. Under “Philosophy and Goals” Marta wrote: “ I believe in a culture of collaboration and giving, and in the ripple effect in all aspects of life or business. Keeping my values close and my loved ones even closer, I am moved by a desire to make positive impact and serve a community of health tech innovators, so that their inspiring ideas become solutions that matter in the hands of those who need them the most.You can find the link to Marta’s profile in the show notes below, and Marta also very kindly worked with the Stanford Byers Center for Biodesign to create a handout that you can also download using the big blue button below.Episode Download:Learn More About BiodesignToday's Topics: Marta's observations on the US and EU markets after living in Silicon Valley for 13 years and moving to Barcelona Nina Capital's vision, and the particular companies & solutions they seek Introduction to Stanford Byers Center for Biodesign, and how it can help avoid pitfalls by going through their 3 step phases How to get through the needs-finding stage, and who can benefit Links and Resources Mentioned: Marta Zanchi on Twitter Marta Zanchi on LinkedIn Standford Biodesign on Twitter Stanford Biodesign on LinkedIn Stanford Biodesign on the Web Stanford Biodesign Re

Our guest is Francesca Wuttke, PhD, the Chief Digital Officer of Almirall. Almirall is an international pharmaceutical company founded in 1943 and based in Barcelona – which is where Francesca is based.Francesca is responsible for developing and executing an end-to-end company-wide digital transformation. In her role, she is responsible for finding use cases to apply digital solutions and services across the business and bring efficiencies that save time, lower costs and open up new business channels for Almirall. Francesca has over 20 years of drug development and healthcare expertise in both the US and Europe, and most recently, she led European investments as Managing Director for the MSD Global Health Innovation Fund and previously held roles at Novartis and Mount Sinai school of medicine, just to name a few. Francesca holds a Ph.D. in Pharmacology from Weill Cornell Graduate School of Medical Sciences and a BA from Cornell University College of Arts and Sciences.In this conversation, Francesca shares her insights on what is being done, and what needs to be done, to accelerate innovation within pharma. Francesca also references a great document called the 12 Commandments for Startup and Corprate Relationships (Click the link below). And finally, she gave us a little insight into a new accelerator program that they’ve developed: the Digital Garden Powered by Almirall. If you want to know more about that program when it is launched in the next few months, be sure to subscribe to our newsletter.Episode Download:12 Commandments For Startup and Corporate Relationships - Developed by Health XL and AlmirallToday's Topics: A quick background of Almirall, its renewes focus on digital transformation and how Francesca sets her priorities on such a broad role The unique challenges and opportunities within the European market How to define and win buy-in of ‘Digital Transformation' within pharma companies Examples of great innovation in pharma like Novartis and Pear Therapeutics, and Otsuka and Proteus Digital Health Effective ways to manage immune response to innovation within a company Sneak preview of the new Digital Garden Powered by Almirall – Subscribe to our newsletter to hear more as it's announced! Links and Resources Mentioned:</st

The topic: Have you ever wondered how much more secure - or perhaps less secure - your organization is compared to your peers in the industry? This could have a significant impact on your business not simply the operational performance of your organization, but on the commercial opportunities as well. With the risks and threats surrounding healthcare data, the stakes are high to make sure that organizations, and all their partners, vendors and clients, are proactive and compliant with the latest requirements.Our guest:Grant Elliott is the President & CEO at Ostendio - a leading provider of cybersecurity and information management software based in northern Virginia. Ostendio is leading the way to make security auditing easier for smaller companies, and affordable and accessible to organizations of any size.Links and Resources:8 Steps to take to protect your OrganizationsOstendio MyVCM Crosswalk Assessment for Healthcare ComplianceGrant Elliot: Twitter  •  LinkedIn  Ostendio:   Twitter  •  LinkedIn  •  WebsiteGet more content:Browse episodes on Digital Health Today Follow us on Twitter @dhealthtoday, Linkedin, Facebook and InstagramGet the full show notes here.---Digital Health Today is made possible by the support of our sponsors. Thank you to Bayer G4ACedars-Sinai AcceleratorDot Health<a href="https://digitalhealthtoday.com/partners

The World Health Organization reports, based on statistics from the end of 2018, that about 38 million people are living with HIV around the world. While about 62% of those – about 23 million people – were receiving antiretroviral treatment by the end of 2018, another 21% of them did not even know their HIV status. That’s about 8 million people who didn’t even know they are infected, and who are at risk of infecting others.The epidemic has impacted different regions of the world disproportionately. For example, Europe has about 2.5 million people living with HIV, and there about 1 Million people in the United States. The African region is the most severely affected, with nearly two-thirds of the total number of people living with HIV worldwide. Nearly 4% of the adult population in Africa are infected, and between 14 to 20% of those individuals are not even aware of their status.South Africa, in particular, has the largest HIV epidemic in the world. Of the global number of people living with HIV, 19% live in South Africa. This country alone also accounts for about 15% of new infections and 11% of AIDS related deaths.To tell us more about the technology and care models being used to treat such an enormous health crisis, I sought out two leaders who have worked at the leading edge of personal and population health for several decades. I wanted to understand more about the solutions that help manage a crisis on this scale, and how health systems are coordinating information and care on both a system and on an individual level. While our conversation focuses specifically on a project tackling HIV, there are some great tools and practices being deployed that can address other chronic diseases and health challenges.Back for his second appearance on Digital Health Today is KP Yelpaala. KP is the Founder and CEO of Access Mobile. KP is an entrepreneur and public health practitioner with a deep understanding of health systems and over 15 years of experience working across the public and private sectors in the United States, East and West Africa, and the Caribbean. He is an expert in national scale health program implementation, technology innovation and the opportunities that lie at the intersection of health and technology policy.Also joining me is Dr. John Sargent of Broadreach. John co-founded BroadReach with Dr. Ernest Darkoh in 2003, and John serves as co-CEO overseeing the development of technology enabled solutions for the consulting business. He has been recognized by the World Economic Forum as the Social Entrepreneur of the Year in 2015 and by Frost & Sullivan with the Visionary Leadership Award in Healthcare.And in a first for me here on Digital Health Today – John is a guest that I’ve known for over 30 years! Yes, John and I went to High School together back in Virginia Beach, Virginia. John was both our class president and our class valedictorian, and he went on to graduate with degrees from Dartmou

Our first State of the Podcast episode! We've been going for 3 years, and we've experienced a lot of growth and success. In this episode, we cover four key topics to shed some light on where we’re focusing our efforts and how we’re having an impact.1) Metrics - Our shows have had over 200,000 downloads, 15,000 followers2) Community - We've developed a network of Ambassadors and a global, engaged audience3) Partnerships - Dozens of partners supporting our growth, relationships and content creation4) Launch of Health Podcast Network to feature other great podcasts that help advance health, care and well-beingWe also cover the service mindset, and how we work to provide value through service to our listeners, partners and sponsors.Thanks for tuning in and being a part of the community! We appreciate the time, focus and hard work you put in to help improve healthcare, and we are pleased to help develop connections and collaborations through the Digital Health Today platform. Please get in touch if there's something we can do to help.Get in touch:- Twitter @healthtechdan- Email: [email protected] Find more on our website at DigitalHealthToday.com/podcasts- Join the Health Podcast Network at HealthPodcastNetwork.com#utprosim #digitalhealth #podcasts #service Learn more about your ad choices. Visit megaphone.fm/adchoices

“We really love this new positioning of high tech meets high touch, to truly change health and well-being.”~ Dr. Rajiv KumarWe’ve all heard the numbers regarding the healthcare spend in the United States. When compared to other developed countries, per capita healthcare spending in the US ($9,892 in 2016) is 145 percent higher than the Organization for Economic Cooperation and Development (OECD) median of $4,033, and yet when comparing outcomes and process measures, the US lags behind. In some areas, such as the rates of premature death and disease burden, the U.S. is also not improving as rapidly as other countries, so the gap continues to grow.Some of the key opportunities to reverse these trends lies in the way employers and employees collaborate and engage in reducing costs. In addition to benefits such as financial savings and optimizing employee benefits, there are additional ways to get a return on the investment such as improved business performance and a great company culture.In this episode we’re diving into the changing aspects of the employee and employer relationship, and how intrinsic and extrinsic motivation can play a key role in improving health and well-being. My guest is Dr. Rajiv Kumar, Chief Medical Officer and President of the Virgin Pulse Institute.With the entrepreneurial spirit that seems to embody all Virgin businesses, it won’t surprise you to hear Dr. Kumar joined Virgin Pulse in 2016 after the company he founded was acquired by Virgin. That company was called ShapeUp, and he led the growth of the company from a two-person, dorm-room startup to a global company with over 100 employees, 800 customers, and 2 million participants around the world. During his time at ShapeUp, he pioneered new approaches to leveraging social connections to enhance employee health and well-being, and he also co-authored several peer-reviewed studies on the relationship between social networks and healthy behavior.Dr. Kumar explains how motivation can lead to new workforce habits, and the unconventional approach that Virgin has to serving their employees.Today's Topics: The focus and services that Virgin Pulse provides along with the organizations they serve Why Virgin Pulse has acquired various companies and its impact as the largest employee health and wellness company in the world How their suite of services combine personalized coaching, remote and group coaching, apps, wearables and other innovations to improve health and well being The synergies between digital tools and human interaction through personalized coaching, and how it affects costs and employee engagement How intrinsic and extrinsic motivation can create the longterm, sustainable change that is needed in the workplace The Virgin Brand’s approach to serving its employees first, and how that gets translated i

Overcoming challenges and accelerating change with Jen Goldsack of the (new!) Digital Medicine SocietyThe use of the term ‘digital health' is continuing to grow, with new subsets of products and services being grouped within it: digital doctor’s visits, digital clinical trials, digital therapeutics, and digital medicine – these are just some of the terms that have burst onto the scene.In this episode, we’re diving into one of the terms in the digital health lexicon: ‘digital medicine'. We explore what digital medicine is, how it is positioned along with digital therapeutics and digital health, and explore what’s needed to make the field of digital medicine stronger, smarter and faster.My guest is Jen Goldsack, the Interim Executive Director of the Digital Medicine Society, a new organization that’s just been launched. Jen has a background in clinical trials, outcomes research, and innovation, and she holds masters degrees from the University of Oxford in England, the University of Pennsylvania, and an MBA from George Washington University.Jen is also a retired athlete; she is a Pan American Games Champion, Olympian and World Championship silver medalist. She’s a dual-national with both British and American citizenship, and currently resides in Florida. Jen also shares her journey from being an elite athlete to the elite field of healthcare, and her motivation for making a real difference to both individuals and populations.Episode Download:Get a Copy of the Notes About the Digital Medicine SocietyToday's Topics: Jen's career as a professional athlete and how she applied those experiences and her competitive nature towards a career in healthcare The definition of ‘digital medicine' and the role of hardware, software, evidence and pharma The current participating companies, stakeholders and products who currently inside the Digital Medicine space The stakeholders in Digital Medicine and the roles and opportunities for patients The three primary challenges that the industry needs to overcome to accelerate development and adoption of digital medicine The mission of the Digital Medicine Society and how they will help overcome the challenges and serve their stakeholders Links and Resources Mentioned: Jen Goldsack on Twitter Jen Goldsack on LinkedIn  Digital Medicine Society on Twitter Digital Medicine Society on the Web Impossibl

Welcome to Coffee Talk! In this episode, we speak with two leaders from one of the companies that help make our platform possible, and we’ll learn more about the work they’re doing to move the industry forward. My guests are from none other than Bayer G4A. Bayer G4A was officially launched as “Grants4Apps” in Berlin in 2013, originally with the aim of funding healthcare mobile apps. Now, six years later, this program has shortened its name to simply ‘G4A’, while also extending it’s global presence to more than 35 countries. Bayer G4A is one of the most successful and highly regarded programs in the industry, and they’ve moved far beyond simply funding the creation of apps. They provide a powerful network of support for early stage businesses with a combination of funding, mentorship, and, perhaps most significantly, they provide opportunities to create commercial partnerships.I’ve invited two of the leaders of the G4A program to give us an update about their work and how the organization is working internally and externally to create opportunities for early stage businesses.With me is Eugene Borukhovich, he’s the Global Head of Digital Health Incubation & Innovation at Bayer, and Sophie Park, Chief of Strategy for the Bayer G4A Digital Health Partnerships.Tune in as we discuss the new format of the G4A program, how it's helping startups succeed, and tips for fostering intrapreneurship and successful partnerships.Get the shownotes to the podcast at https://digitalhealthtoday.com/coffeetalk and find out more about Bayer G4A at http://g4a.health Learn more about your ad choices. Visit megaphone.fm/adchoices

How a former F-16 fighter pilot is flying high with new FDA and CE-registered medical applications using VR?~ Virtual Reality, Augmented Reality, Mixed Reality – We’ve spoken to leaders about these technologies in our conversations with Dr. Brennan Spiegel, Dr. Ashya Vahabzadeh, Dr. Shafi Ahmed, Dr. Rafael Grossman and Dr. Justin Barad. Those guests, who all happened to be doctors leading in the field, spoke about their work across a wide variety of use cases, such as patient education, treating mental health condition, pain management, surgical training and actual live surgery.In this episode, we discuss what makes VR such a powerful tool in health care, and tips on how to start a medical device company with no previous medical device or startup experience. We also dive into how the business was helped by getting the FDA involved early. Finally, we also discuss how VR bridges therapy from the hospital to the home, and some of the applications for motor and cognitive treatment, disease progression, response to therapy and much more.Eran Orr is the CEO and Founder of XR Health, an Israeli company with offices in Boston, Massachusetts. XR Health creates an extended-reality platform that combines medical applications with advanced data analytics to provide a comprehensive solution for clinicians and patients. XRHealth is the first Certified Virtual Reality Medical Company to develop FDA/CE Registered Medical Applications. Their products focus on motor, cognitive, physical, psychological, postural ability and pain assessment and treatment.Today's Topics: How Eran got interested in developing VR solutions and his transition from the military to entrepreneurship The problems that VR can be used to help solve in healthcare Three key reasons that VR is effective as a healthcare technology How VR can be classified as a medical device, and the costs and processes involved The role of partnerships with VR leaders like Oculus How getting involved with the FDA from the beginning helped prepare XR Health for success The sales cycle and strategy for bringing customers on board The meaning behind the company's new name, XR Health, and the future of VR in healthcare Links and Resources Mentioned: Eran Orr on Twitter  Eran Orr on Linked

Combining commercial nous with digital tools to deliver universal access to healthcareThere are over 1.2 billion people living in Africa, and another 1.3 billion living in India. Together they account for about 34% of the world’s population. These two regions represent some of the highest levels of healthcare burden, and some of the lowest numbers of healthcare professionals.For example, in Africa, there are only 2.3 healthcare workers per 1,000 people. Compare that to the Americas where you’ll find there are more than 10 times as many: 24.8 healthcare workers per 1000 people. To look at it another way, Africa has a deficit of 2.4 million doctors and nurses – so if you’re looking for a place where you can have a really huge impact on a population in need, there are a few big targets for you in the 54 countries of Africa, in addition to another 1.3 billion people in India.In this episode I spoke to Emmanuel Blin. Emmanuel is the founder and CEO of Tech Care for All (TC4A). He grew up in sub-Saharan Africa and he has a deep commitment to addressing the challenges and inequalities that are present there.In 2017, after 20 years of service in the pharmaceutical industry, Emmanuel decided to invest his energy in changing health outcomes in the poorest corners of our world. He created a for-profit, social impact company called Tech Care for All whose goal is to accelerate digital health in Africa and Asia as a key enabler to improving health outcomes in underserved communities. His vision is to bridge the very best digital health innovation that’s happening across the U.S., Asia, Europe and Africa. Emmanuel is a Digital Health and Social Impact Entrepreneur and he lives in Brussels with his wife and four children.In previous programs, we’ve spoken with leaders who are developing solutions and models that help serve the people in these underserved communities – Some other episodes that you can reference include episode 13 with KP Yelpaala founder and CEO at Access Mobile, episode 14 with Neil Jordan Worldwide general manager of health for Microsoft, and episode 26 with Kate Newhouse when she was CEO of Doctor Care Anywhere.I encourage you to go back and tune into those episodes to hear what other companies and leaders are doing to innovate and transform health.Today's Topics: Emmanuel's background at Bristol Myers Squibb before TC4A The impact of new technology on drug discovery and commercial ways of working  The key challenges in underserved areas such as distance to doctors and hospitals, and access to personnel and health workers How thes

How the Novartis Biome is pioneering new approaches to digital health innovation?Take a look online and you’ll find hundreds of articles proclaiming that Pharma’s business model is broken and that the entire sector is in the middle of an innovation crisis. Whether you agree or disagree, there’s no question that the industry is extraordinarily competitive and the challenge of bringing effective drugs to market is growing. Adapting to new ways of working and driving new tech and innovation across an entire industry is never easy, and with the long development cycles for new drugs and the low drug development success rates, the challenges are even bigger. But where some see a crisis, others see opportunity, and making the most of that opportunity can take many different forms and approaches.In this episode, I speak with Jake LaPorte – someone who sees that opportunity and has developed a new program to give innovative digital health companies a boost. Jake is the Global Head of Digital Development at Novartis and responsible for leading the company’s digital efforts within their Global Drug Development organization. He also is one of the founders and the Managing Director of BIOME—which is the first-ever, externally branded innovation lab by Novartis.Jake completed his Ph.D. in Organic Chemistry from Harvard University, and received his B.Sc. in Biochemistry and Mathematics, from the University of Delaware. While traveling with his wife, he read Ray Kurzweil’s book The Singularity is Near and he became captivated by the possibility of digitizing the Pharmaceutical engine.Well, words matter, because ever since reading that book, he has focused his career on making that concept a reality. In this episode, Jake explains how the Novartis Biome is making a real impact on accelerating digital health solutions in drug development and discovery.Today's Topics: Brief background about Novartis, their portfolio and key therapeutic areas Specific challenges in the Pharmaceutical industry and how they can be overcome The Biome program, how it got started and the types of support companies get from the program Overview of the Biome companies, how they were selected and the value for participants and Novartis from the partnership Metrics and success factors of the Biome program and advice for others working on open-innovation projects Links and Resources Mentioned: Jake LaPorte on LinkedIn Novartis on Twitter Novartis on LinkedIn Novartis Biome on the Web <a href="https://www.statnews.com/

How can better development resources and new business models enable ‘bring-your-own-app' solutions?Application Programming Interfaces. APIs. We hear a lot about them and their use is really taking off in healthcare. Providers want to use them to become more efficient and provide better connectivity across their enterprise. Patients are also demanding the same modern technology, user experiences and access to health information that we’ve come to expect in nearly every other user-facing industry.Despite the focus and investment in digital transformation in healthcare, there still is a lack of shared infrastructure across the industry. When health systems adopt new technologies, interoperability isn’t simply a nice to have, it’s a requirement! But what does interoperability mean anyway? And how can it be achieved without having to start from scratch and repeat the same integrations when thousands of other companies are working to achieve similar results?To maximize efficiency and address market failings in the health software industry, we need broad adoption of open tools and standards to integrate software from apps to the enterprise. With me to talk about it is Niko Skievaski, the cofounder and president of Redox. Niko has a background in economics and in 2014 he co-founded Redox – a health technology company that accelerates development and distribution of healthcare software solutions to securely and efficiently exchange data. They’ve partnered with 500 digital health vendors who use the Redox Engine platform to interoperate with nearly 450 healthcare delivery organizations using about 40 different legacy EHR vendors. They also throw one heck of a great taco party – if you’re going to any of the major conferences like JP Morgan, HIMSS, SXSW – then be sure to join them!Today's Topics: Key market failures for software businesses and solutions in healthcare How new approaches for integration can lower costs, shorten sales cycles and increase sales How new procurement models, used by collaboration companies like Slack, can increase the rate of adoption in healthcare Understanding the challenges of interoperability and why it remains a contentious area in digital health Links and Resources Mentioned: Niko Skievaski on Twitter Niko Skievaski on LinkedIn Redox on Twitter Redox on LinkedIn Redox on the Web Digital Health Events Join Digital Health Today Digital

In this episode we dive into some of the cities, countries and winning strategies that are leading the transformation of health for the billions of people that live in APAC.Tony Estrella is an investor, advisor, and global digital health expert. He has experience all over the world having lived and worked in Asia, the US, and Europe as a startup founder, investor and corporate innovation leader.One of the things that we like to do on this program is bring an international perspective on the challenges that we’re facing in healthcare systems around the world. We’ve had leaders from California to Israel, and Finland to subsaharan africa, but even still there are huge parts of the world we have yet to cover. One of those major regions is Asia Pacific, and in this episode, we dip our toes in the water – pardon the expression.While everyone knows that there are huge numbers of people in this region, there are also tremendous opportunities for investors and healthcare companies of all sizes. When I was at the Frontiers Health conference in Berlin last November, I spent some time with a friend of mine who lives in Singapore, and I invited him on the show to give us a little insight into the similarities and differences in the market, and how companies can be and are being successful. So, this episode is like a little APAC 101 summary to outline some of the cities, countries and strategies that are working as leaders and organizations transform health for the billions of people that live in APAC.Tony Estrella is an investor, advisor and global digital health expert. He has experience all over the world having lived and worked in Asia, the US, and Europe as a startup founder, investor and corporate innovation leader.Tony works with companies who are developing solutions for Asia to change the face of cancer, human longevity, and population health by deploying leading tech in AI, Genomics, Blockchain, and smart devices.Tony is a graduate from Wharton and got an engineering degree from the University of Pennsylvania. He now resides in Singapore with his wife and daughter, and I can’t forget to talk about this – he’s a newly minted fiction writer. Tony has written a book entitled Comatose that is now available for purchase on Amazon and other book retailers. We talk about this project as well on this episode.Episode Download:Get a Copy of the APAC101 NotesToday's Topics: Understanding the APAC market, which countries are actively involved and opportunities and challenges The key similarities between East and West when it comes to progress and investment in the healthcare system The growth of health technology in the APAC market and the types of investments companies are makin

Today we’re diving into the topic of Mental Health. It’s a topic we’ve covered before on this program, like in episode 63 with Dale Beerman of Think Pacifica, and in episode 21 with Dr. Arshya Vahabzadeh from Brain Power. In those episodes, we explored the use of mobile apps and wearables, and we looked at some problems that are being solved using these technologies.We often think of mental health as something that is just that – “mental” health – and the connections to physical health, and even the numbers of people who die due to poor mental health, are often under appreciated. We also know that if we increase activity and physical exercise it can help relieve symptoms of stress and improve aspects of our mental health. Wouldn’t it be great if there were tools available that could help measure and quantify our mental health based on our physical activities and behaviors? Maybe even serve as an early warning system?Well, that’s why I wanted to introduce you to our next guest. His company is doing pioneering work in measurement science to provide continuous, objective measures of cognition and mood that can potentially alert patients and providers to early signs of mental health deterioration.My guest is Dr. Thomas R. Insel, he is the Co-Founder & President of Mindstrong Health based in California. He is a psychiatrist and neuroscientist, and previously he was a Director of the National Institute of Mental Health, a Professor of Psychiatry at Emory University, and a leader of Verily’s Mental Health Team. Tom’s here to tell us about the research and work they’re doing at Mindstrong Health to use information from cell phones to drive better, earlier and deeper understandings about mental health.I was introduced to Tom my Marco Mohwinckel and George Goldsmith over at Compass Pathways, a UK-based company working to develop treatments to empower patients suffering with mental illness. They are doing that by combining neuroscience, psychotherapy, psychopharmacology, and digital platforms. Thanks Marco and George for the introduction to Tom.Today's Topics: The relationship between Physical Health and Mental Health Where does Mental Health space sit in the Healthcare Ecosystem Dr. Insel's work in Mindstrong and an introduction to Digital Phenotyping How does Digital Phenotyping work and how will it assist in understanding and solving mental health issues The current business model of Mindstrong Health, where they are now, and how can consumers and organizations interact with their projects Where will Mental Health be years from now in relation to the developments of this new technological intervention

In this episode, we’re taking on the topic of Digital Therapeutics. At the CNS Summit last year, I had the opportunity to meet our guest: Megan Coder. Megan is the founder and executive director of the Digital Therapeutics Alliance. The Digital Therapeutics Alliance, or DTA as you may hear it called, was launched in 2017 to broaden the understanding, adoption, and integration of clinically-validated digital therapeutic solutions into mainstream healthcare through education, advocacy, and research.Megan has more than a decade of experience in the healthcare industry. She’s held roles that span from direct delivery of patient care, to leading the strategic growth within the digital health sector. Prior to DTA, Megan worked with Voluntis, Iodine, the Pharmaceutical Care Management Association, and the Pharmacy Technician Certification Board. She’s a qualified pharmacist and a proud graduate from the University of Wisconsin like our guest in episode 63, Dale Beerman.Enjoy this update on digital therapeutics and be sure to download the industry report below!Today's Topics: The ‘official' definition of ‘Digital Therapeutics' The history and evolution of Digital Therapeutics The similarities and differences of Digital Therapeutics and traditional Prescription Therapeutics The current state of regulatory pathways available for Digital Therapeutics How the FDA and other regulatory bodies assess the viability of Digital Therapeutics The response to Digital Therapeutics by the traditional pharmaceutical industry The founding members of the Digital Therapeutics Alliance and their mission and goals The key stakeholders that are driving access and adoption of Digital Therapeutics Links and Resources Mentioned: Megan Coder on Twitter Megan Coder on LinkedIn Digital Therapeutics Alliance on Twitter Digital Therapeutics Alliance on LinkedIn Digital Therapeutics Alliance on the Web Digital Therapeutics Industry Report – pdf Digital Health Events Join Digital Health Today This episode of Digital Health Today is made possible thanks to our sponsors. Thank you! Learn more about your ad choices. Visit megaphone.fm

Lihi Segal on applying technology and predictive models to manage glucose levelsIn this episode, we’re diving into the research, and a brand new solution, focused on the growing understanding of the human microbiome – the microorganisms that help protect us against germs, break down food, and produce vitamins.What work is being done to actually enlist the microbiome in the fight against disease? Can we leverage our understanding not just to preserve health but also to actually prevent or treat metabolic disease? Here on Digital Health today, it is our job and privilege to find the leaders who are breaking new ground, and I’m pleased to introduce you to one of those leaders on this podcast.With me on this episode is Lihi Segal, the CEO and Co-Founder of DayTwo. Lihi cofounded Day Two in 2015 to bring personalized health solutions based on the gut microbiome into the consumer mainstream. Before starting DayTwo, Lihi led business and financial operations as the COO and CFO of Sisense, which is a provider of business intelligence and analytics software. She’s also a qualified lawyer, and has an LLB from the Tel-Aviv University and an MBA from Northwestern University in the US.For another episode about the human microbiome, tune into episode 48 where we spoke with Dr. Azza Gadir from Harvard about the relationship between the microbiome and the development and management of food allergies.Videos:What is the best diet for humans? | Eran Segal | TEDxRuppinPersonalized Nutrition/ Cell November 19, 2015 (Vol. 163, Issue 5)This episode of Digital Health Today is made possible thanks to our sponsors. Thank you. Learn more about your ad choices. Visit megaphone.fm/adchoices

Our guest in this episode is Todd Pope, the President and Chief Executive Officer of TransEnterix, a company that is digitizing the interface between laparoscopic surgeons and patients through the use of their robot. Todd shares some of the ways that robotics are changing the landscape of surgery today, and he explains how technologies such as artificial intelligence and computer vision further enhance these capabilities.Todd has more than 25 years of experience in key leadership positions within the medical device industry. He was the Worldwide President at Cordis, which is a multibillion-dollar division within Johnson & Johnson’s medical device sector, and he previously held a number of leadership there at Johnson & Johnson as well as Boston Scientific. He was also named as one of Time Magazine's “50 Most Influential People in Healthcare” for 2018.Are robots really ‘Digital Health'?When people ask me to define Digital Health I normally include a whole host of products, software and technology – everything from 3D printing and Augmented Reality, through to digital therapeutics and virtual reality. One of the technologies that I include in the list is robotics.We’re seeing huge leaps in other technologies like AI, computer vision, augmented reality, and as those technologies begin to converge you’ll see even more capabilities being delivered through things like robots. We’re already seeing a boom in consumer robotics around the world. The tech that has transformed manufacturing floors for years is moving well beyond that environment and into places like hotels, bars, and even in homes.And although robots have been around since well before the term ‘digital health' was coined, their impact on healthcare is at an infancy stage. The robots of today are bigger, have fewer applications, and are far less intelligent than robots will be in 5 to 15 years from now. The same can be said about the improvements to computers and mobile devices – but you didn’t wait to begin using computers 5-15 years ago until the smartphone or tablet computer was invented. You used what was available and increased your dexterity and applications of these machines as the technology changed and improved. So why should the healthcare sector wait 20 years for some future generation of robot, and overlook the capabilities and benefits that robots can deliver today?Tune into this episode to hear Todd's insights on the ingredients for success in creating robotic technology, and how TransEnterix has addressed the entire value chain that shapes how these important devices can be adapted to fit into the business models and cost constraints of the hospitals that need them. Plus, he shares how other technologies, such as AI and AR, can be incorporated into robots for a more connected and data rich experience in the OR.Today's

Redesigning Healthcare with a Generational PerspectiveHow do the experiences of different generations of people shape and inform their attitudes, expectations and perceptions of healthcare today and in the future? And if we focus our attention on redesigning healthcare for those current generations of adults who place the highest demands on it today, are we overlooking the needs of younger generations of adults and future generations who don’t yet have similar demands of the system?In this episode we explore these issues with Dr Eliza Filby. Dr. Filby is a historian, author and consultant who understands the differences in values and behaviors across different generations. She is currently writing a book called ‘Our Place in Time’, and she works with companies to address multi-generational challenges such as recruiting Generation Z employees, retaining Millennial talent, and dealing with a multi-generational client or employee base. We dive into how people in Generation Z have an entirely different view and perception on data, automation and the value of personal and human interactions, and the impact that these differences may have on their demands and expectations of healthcare solutions and experiences.Today's Topics: The characteristics or traits of Generation Z: 1. Skepticism – skeptical towards establishment, politician, products and even the future 2. The DIY generation – because of the exposure during deep recession. Setting up businesses online. Highly savvy and entrepreneurial 3. Much more comfortable with the notion of fluidity – that nothing is permanent 4. Incredibly serious – not indulging in the traditional right of passage. They don't drink or smoke as much, or have as much sex as other generations at their age. However, they do have high number of anxiety and mental issues like depression. How Generation Z experience physical media consumption in comparison to the the online world How they perceive and prioritize personal interactions Generation Z's interaction with Health and data, and their engagement with ‘luxury' The attitude of Gen Z towards healthcare products, data security and their collective approach rather than individualistic values Links and Resources Mentioned: Eliza Filby on Twitter  Eliza Filby on LinkedIn Eliza Filby on the Web  Digital Health Events Join Digital Health Today This episode of Digital Health Today is made possible <a href="https://digitalhealthtoday.com